Insomnia drug approved in Europe
Studies have shown that this drug improves sleep and daytime performance in people with insomnia, without causing a sedative effect the next day, a...
News from Institute of Neurosciences
The Hospital CLÍNIC-IDIBAPS is leading a study to identify people who may develop Parkinson’s disease
Researchers from the Hospital Clínic-IDIBAPS are leading a study to obtain information on 10,000 healthy people who do not have Parkinson's disease...
Long-term effects of antidepressants
A study with the participation of millions of people has concluded that antidepressants do not improve the long-term quality of life of patients. D...
Chronic consumption of cannabis and cocaine can cause psychotic disorders
According to the latest data from the Ministry of Health, alcohol and tobacco are still the most common drugs taken legally in Spain, followed by t...
Dr. Mª Josep Martí: "The main aim is to slow down, stop or even reverse the processes of the disease”
Interview with Dr. Mª Josep Martí, neurologist and head of the IDIBAPS Parkinson’s Disease and other Neurodegenerative Movement Disorders research...
Interview with Dr. Yaroslau Compta Hirnyj: “Russian society lives under a dictatorship where there is no freedom”
On 24 February, the Russian President Vladimir Putin ordered an attack on the Donbas region of Ukraine. It was the start of a war with incalculable...
The Hospital Clínic, first hospital in Spain to carry out transorbital surgery to extract skull base tumours
The Hospital Clínic de Barcelona is consolidating its transorbital surgery programme for patients with skull base tumours. This surgery is led by t...
The BBVA Foundation and Hospital Clínic de Barcelona award two Joan Rodés-Josep Baselga Advanced Research Contracts in Oncology and Neurodegenerative Diseases
The Joan Rodés-Josep Baselga Advanced Research Contracts in Oncology and Neurodegenerative Diseases, awarded by the BBVA Foundation and Hospital Cl...
A combination of treatments significantly improves the prognosis of stroke patients
The study, led by researchers from Hospital Clínic-IDIBAPS, will be a paradigm shift in the treatment of the disease worldwide
People with schizophrenia who take part in clinical trials may not be representative of the population with this disorder
A new international study, in which Hospital Clínic-IDIBAPS researchers took part, shows that people with schizophrenia who are not eligible for cl...